Biotechnology company MannKind Corp. said Monday that the Food and Drug Administration has requested more information about the inhaled insulin Afrezza, prompting its shares to plummet.
March 15 (Bloomberg) — MannKind Corp. , the biotechnology company run by billionaire inventor Alfred Mann , failed to win approval from U.S. regulators to market its inhaled insulin drug, Afrezza, for people with diabetes.
This entry was posted on Monday, March 8th, 2010 at 7:16 pm and is filed under Biotechnology .
08 March 2010.
Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.
Biotechnology company Isis Pharmaceuticals Inc. said Monday its fourth-quarter loss widened on a boost in research and development costs.
Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.
Shares of drug developer Anthera Pharmaceuticals are climbing in their market debut Monday.
Biodel Inc.
Japanese drugmaker Astellas Pharma Inc. said Monday it will take a $3.5 billion takeover offer for OSI Pharmaceuticals directly to shareholders after being rebuffed several times by executives of the U.S
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.